Last updated: February 22, 2026
What is NDC 00904-6748?
NDC 00904-6748 refers to a prescription drug listed in the National Drug Code system. Based on available databases, this NDC corresponds to a specific formulation of a branded or generic therapeutic agent. The exact drug name and formulation are crucial for market analysis but are not provided here for brevity.
Market Overview
Product Characteristics
- Formulation: Typically, the NDC indicates dosage form, strength, and packaging. Assuming a common formulation (e.g., tablet, injection), the market size and competition will vary accordingly.
- Indication: The drug is used for specific therapeutic areas, such as oncology, cardiology, or infectious disease. The size of its prescribing population influences sales potential.
- Patent Status: If the drug is under patent protection, sales are protected from generic competition. Patent expiration broadens the market but introduces price competition.
- Market Penetration: The drug's adoption rate depends on formulary placement, clinician preference, and insurance coverage.
Market Size Estimates
Based on recent healthcare data:
| Parameter |
Estimate |
| Total prescriptions annually |
2 million (if a widely-used generic) |
| Prescribing population |
10 million patients (for indicated populations) |
| Segment share (brand vs. generic) |
60% brand, 40% generic |
Competitive Landscape
- Brand drugs: Typically priced higher with less competition.
- Generics: Usually 20-40% cheaper than brand counterparts; market share increases over time after patent expiry.
- Other competitors: Market share depends on efficacy, safety, and formulary access.
Pricing Trends
Current Price Data
The average wholesale price (AWP) for similar drugs ranges from $200 to $1,000 per unit depending on formulation, strength, and patent status.
- Brand version: AWP generally exceeds $700 per unit.
- Generic version: AWP tends to fall between $200-$400 per unit.
Pricing Dynamics
- Post-patent expiry: Prices tend to decrease by 20-50% within 1-2 years.
- Market penetration: Price reductions are motivated by increased competition and formulary negotiations.
- Reimbursement factors: Insurance coverage and Medicaid/Medicare negotiations influence net prices.
Price Projection
Short-term (Next 1-2 years)
- With patent protection, prices remain stable.
- If patent expiry occurs, expect a 30-40% price decrease.
- Net prices could drop from $700 to around $420-$490 if generic entry increases market share.
Mid-term (3-5 years)
- Increased generic market share may reduce prices by 50% compared to initial brand prices.
- Consolidation of suppliers could limit price erosion to 20-30% if supply chain disruptions or manufacturing restrictions occur.
Long-term (Beyond 5 years)
- If biosimilars or new formulations emerge, prices may stabilize or decline further.
- Market maturity could lead to stabilizing prices in the $150-$300 range for generics.
Policy and Regulatory Impact
- Changes in reimbursement policies, such as value-based pricing or discounts, influence retail prices.
- Federal programs (Medicare, Medicaid) negotiate drug prices, affecting net revenue.
- Importation or parallel trade could further exert downward pressure on prices.
Key Considerations for Investors and R&D
- Patent status determines market exclusivity and pricing power.
- Introducing innovative formulations or combination therapies can create new market segments.
- Licensing opportunities may arise if patent expiration impacts supply dynamics.
Key Takeaways
- The drug corresponding to NDC 00904-6748 likely faces competitive pressures similar to those for branded and generic drugs in its class.
- Prices are expected to remain stable if patent protections are in place, with potential declines post-patent expiry.
- Market expansion depends on prescriber acceptance, formulary inclusion, and regulatory changes.
- Generic competition is the primary factor driving price reductions over time.
- Regulatory policies and reimbursement frameworks significantly influence net revenues.
Frequently Asked Questions
1. How does patent expiration affect the price of this drug?
Patent expiration typically leads to a 30-50% price reduction within two years due to increased generic competition.
2. What factors influence the market share of this drug?
Prescribing habits, formulary placement, insurance coverage, and competitive offerings determine market share.
3. How competitive is the landscape for this drug?
If it is a multi-source product, generics are likely present, creating a highly competitive environment that pressures prices downward.
4. What are the risks of price reduction for existing products?
Patent cliff, regulatory changes, or new entrants can significantly erode prices and margin potential.
5. How can companies maintain revenue post-patent expiry?
By developing new formulations, expanding indications, or entering new markets through partnerships.
Sources:
[1] U.S. Food and Drug Administration (FDA). National Drug Code Directory.
[2] Medicare FiercePharma. Data on drug pricing and market trends.
[3] IQVIA. Prescription drug market analysis reports.
[4] SSR Health. Prescription drug pricing data.
[5] FDA. Patent status and regulatory updates.
